Filing Details
- Accession Number:
- 0001209191-21-008231
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2021-02-05 17:50:43
- Reporting Period:
- 2020-12-31
- Accepted Time:
- 2021-02-05 17:50:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1632384 | C Joseph Galante | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-09 | 75 | $3.25 | 27,217 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-12 | 75 | $3.23 | 27,292 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-13 | 75 | $3.21 | 27,367 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-14 | 75 | $3.14 | 27,442 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-15 | 75 | $3.07 | 27,517 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-16 | 75 | $3.07 | 27,592 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-19 | 75 | $3.03 | 27,667 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-20 | 75 | $3.04 | 27,742 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-21 | 75 | $3.04 | 27,817 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-22 | 75 | $3.08 | 27,892 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-23 | 75 | $3.04 | 27,967 | No | 4 | L | Direct | |
| Common Stock | Acquisiton | 2020-10-26 | 75 | $3.02 | 28,042 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-10-27 | 75 | $3.06 | 28,117 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-10-28 | 75 | $2.97 | 28,192 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-10-29 | 75 | $3.02 | 28,267 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-10-30 | 75 | $2.99 | 28,342 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-02 | 75 | $2.97 | 28,417 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-03 | 75 | $2.99 | 28,492 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-04 | 75 | $3.01 | 28,567 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-05 | 75 | $2.98 | 28,642 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-06 | 75 | $2.99 | 28,717 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-09 | 75 | $3.06 | 28,792 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-10 | 75 | $3.09 | 28,867 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-11 | 75 | $3.12 | 28,942 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-12 | 75 | $3.03 | 29,017 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-13 | 75 | $3.04 | 29,092 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-16 | 75 | $3.05 | 29,167 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-17 | 75 | $2.96 | 29,242 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-18 | 75 | $3.01 | 29,317 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-11-19 | 75 | $2.98 | 29,392 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | L | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020.
- Filing 2 of 3
Billionaire Hedge Funds
